重症虚血肢の世界市場レポート 2024年

重症虚血肢市場規模は近年力強く成長しています。2023年の32億9,000万米ドルから2024年には35億8,000万米ドルに、CAGR8.6％で拡大します。過去に見られた成長は、糖尿病患者の増加、タバコの消費、高血圧の流行、血管イメージングの進歩、血管内インターベンションの拡大、医学研究と臨床試験の進歩に起因しています。

予想される糖尿病と末梢動脈疾患の急増は、当面の重症虚血肢治療市場の拡大を牽引する構えです。糖尿病は血糖値の上昇を伴う代謝障害を特徴とし、末梢動脈疾患は下肢動脈の狭窄を指し、手足への血流低下につながります。これらの疾患は、血管合併症や切断のリスクを著しく高め、重症虚血肢の発生に寄与しています。糖尿病や末梢動脈疾患の有病率の上昇は、重症虚血肢市場の成長の原動力となっています。例えば、2022年1月の国際糖尿病連盟のデータによると、20-79歳の糖尿病の世界有病率は2021年に5億3,660万人に達し、2045年には12.2％増の7億8,320万人になると予想されています。さらに、オックスフォード大学出版局が2023年3月に発行した雑誌によると、2020年には2億人以上が末梢動脈疾患に罹患しており、2045年までに50％近く急増すると予測されています。したがって、これらの疾患の罹患率の増加が重症虚血肢治療市場を刺激しています。

2023年の重症虚血肢治療市場では北米が最大地域でした。重症虚血肢市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 重症虚血肢市場の特徴

第3章 重症虚血肢市場の動向と戦略

第4章 重症虚血肢市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の重症虚血肢市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 重症虚血肢市場セグメンテーション

• 世界の重症虚血肢市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• デバイス
• 薬剤
• 手術
• 世界の重症虚血肢市場、薬剤別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 降圧剤
• 抗血小板薬
• 抗血栓剤
• その他の薬
• 世界の重症虚血肢市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 診療所
• その他の用途

第7章 重症虚血肢市場の地域および国分析

• 世界の重症虚血肢市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の重症虚血肢市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋の重症虚血肢市場

第9章 中国の重症虚血肢市場

第10章 インドの重症虚血肢市場

第11章 日本の重症虚血肢市場

第12章 オーストラリアの重症虚血肢市場

第13章 インドネシアの重症虚血肢市場

第14章 韓国の重症虚血肢市場

第15章 西欧の重症虚血肢市場

第16章 英国の重症虚血肢市場

第17章 ドイツの重症虚血肢市場

第18章 フランスの重症虚血肢市場

第19章 イタリアの重症虚血肢市場

第20章 スペインの重症虚血肢市場

第21章 東欧の重症虚血肢市場

第22章 ロシアの重症虚血肢市場

第23章 北米の重症虚血肢市場

第24章 米国の重症虚血肢市場

第25章 カナダの重症虚血肢市場

第26章 南米重症虚血肢市場

第27章 ブラジルの重症虚血肢市場

第28章 中東の重症虚血肢市場

第29章 アフリカの重症虚血肢市場

第30章 重症虚血肢市場の競合情勢と企業プロファイル

• 重症虚血肢市場の競合情勢
• 重症虚血肢市場の企業プロファイル
  • Medtronic Plc
  • Boston Scientific Corporation
  • ThermoGenesis Holdings Inc.
  • Abbott Laboratories
  • Pluri Biotech Ltd.

第31章 世界の重症虚血肢市場の競合ベンチマーキング

第32章 世界の重症虚血肢市場競争力ダッシュボード

第33章 重症虚血肢市場における主要な合併と買収

第34章 重症虚血肢市場の将来展望と可能性分析

第35章 付録

“Critical Limb Ischemia Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on critical limb ischemia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for critical limb ischemia? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The critical limb ischemia market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Devices; Drugs; Surgery
• 2) By Medication: Antihypertensive Agents; Antiplatelet Drugs; Antithrombotic Agents; Other Medications
• 3) By Application: Hospital; Clinic; Other Applications
• Companies Mentioned: Medtronic Plc; Boston Scientific Corporation; ThermoGenesis Holdings Inc.; Abbott Laboratories; Pluri Biotech Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Critical limb ischemia treatment involves the restoration of blood flow to areas affected by critical limb ischemia, a chronic condition characterized by severe blockages in the blood vessels of the hands and legs, leading to numbness and pain. Treatment modalities encompass a range of approaches, including medication, surgical interventions using devices, and other therapeutic measures.

The primary types of critical limb ischemia treatment include devices, drugs, and surgery. Embolic protection devices (EPDs) are medical devices designed to trap blood and luminal debris, preventing plaque debris from reaching the distal bed. Medications used in the treatment include antihypertensive agents, antiplatelet drugs, antithrombotic agents, and others. These treatments are administered in various healthcare settings, including hospitals, clinics, and other medical facilities.

The critical limb ischemia market research report is one of a series of new reports from The Business Research Company that provides critical limb ischemia market statistics, including critical limb ischemia industry global market size, regional shares, competitors with a critical limb ischemia market share, detailed critical limb ischemia market segments, market trends and opportunities, and any further data you may need to thrive in the critical limb ischemia industry. This critical limb ischemia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The critical limb ischemia market size has grown strongly in recent years. It will grow from $3.29 billion in 2023 to $3.58 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth observed in the historical period can be attributed to an increase in cases of diabetes, tobacco consumption, the prevalence of hypertension, advancements in vascular imaging, the expansion of endovascular interventions, and progress in medical research and clinical trials.

The critical limb ischemia market size is expected to see strong growth in the next few years. It will grow to $5.02 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The anticipated growth in the forecast period can be attributed to advances in regenerative medicine, an emphasis on early intervention, the increasing prevalence of obesity, global health initiatives, and patient education programs. Noteworthy trends in the forecast period include the adoption of wearable health technologies, the expansion of telemedicine and remote patient monitoring, the integration of artificial intelligence (AI), the promotion of patient-centric care models, and the rise of minimally invasive interventions.

The anticipated surge in diabetes mellitus and peripheral artery diseases is poised to drive the expansion of the critical limb ischemia treatment market in the foreseeable future. Diabetes mellitus characterizes a metabolic disorder involving elevated blood glucose levels, while peripheral artery disease refers to the narrowing of leg arteries, leading to reduced blood flow to the limbs. These conditions significantly heighten the risk of vascular complications and amputation, thereby contributing to the occurrence of critical limb ischemia. The escalating prevalence of diabetes mellitus and peripheral artery diseases acts as a driving force behind the growth of the critical limb ischemia market. For example, as per data from the International Diabetes Federation in January 2022, the global prevalence of diabetes among 20-79-year-olds reached 536.6 million in 2021, expected to rise by 12.2% to 783.2 million by 2045. Furthermore, a journal published by Oxford University Press in March 2023 indicated that over 200 million individuals were affected by peripheral artery diseases in 2020, projected to surge by nearly 50% by 2045. Hence, the increasing incidence of these diseases fuels the critical limb ischemia treatment market.

The escalating investments in healthcare infrastructure are projected to propel the growth of the critical limb ischemia treatment market in the forthcoming years. Healthcare infrastructure investment encompasses the allocation of financial resources towards the development, enhancement, and maintenance of essential physical structures, facilities, and systems supporting healthcare service delivery. In the context of critical limb ischemia (CLI) treatment, healthcare infrastructure investments play a pivotal role by providing essential facilities, equipment, and resources for efficient diagnosis and treatment. For instance, according to the 2021-2030 National Health Expenditure (NHE) report by the Centers for Medicare & Medicaid Services in March 2022, national health spending is anticipated to grow at an average annual rate of 5.1% between 2021 and 2030, reaching an approximate $6.8 trillion by 2030. Over the same period, Medicare and Medicaid expenditures are expected to increase by 7.2% and 5.6% annually, respectively. Consequently, heightened investments in healthcare infrastructure drive the critical limb ischemia treatment market's expansion.

Technological advancements stand out as a prominent trend gaining traction within the critical limb ischemia treatment market. Key enterprises operating in this domain are embracing new technologies to bolster their market standing. For instance, in January 2021, the Society for Vascular Surgery (SVS) in the United States launched three novel mobile applications catering to chronic limb-threatening ischemia treatment. These applications include the VQI CLTI Mortality Prediction Model, SVS Threatened Limb Classification [Wi-Fi] calculator, and Global Limb Anatomic Staging System [GLASS] calculator. Uniquely designed, these apps assist physicians in managing chronic limb-threatening conditions, enabling real-time estimation of patient risk, assessment of limb threat severity, and evaluation of disease complexity.

Key players in the critical limb ischemia market are strategically focusing on innovative solutions, such as a clinically engineered immobilization solution for the patient's leg, to establish a competitive edge in the market. These solutions delicately immobilize the patient's leg during fluoroscopy-guided treatments, providing crucial pressure management for individuals prone to painful ulcerations. For instance, in January 2022, Adept Medical, a New Zealand-based medical equipment manufacturer, introduced its Lower Leg Support product. This device is tailored to gently immobilize a patient's leg during fluoroscopy-guided critical limb ischemia treatments. Equipped to perform both endorotation and exorotation, the Lower Leg Support offers versatile positioning options while maintaining the foot in a slightly plantar-flexed posture for optimal imaging. Its ergonomic design aligns the leg to meet procedural requirements for lower limb interventions. The gadget features an adaptable footplate, enabling usage on either the left or right foot. Moreover, if foot manipulation is necessary during the procedure, the footplate can be entirely removed, allowing access for distal artery procedures, ultrasound imaging, and effective pressure management for patients experiencing frequent painful ulcerations. Additionally, the device includes soft foam straps to gently immobilize patients during conscious sedation.

In April 2021, Cardiovascular Systems Inc. (CSI), a prominent US-based medical device company, announced an undisclosed investment and acquisition option with CarePICS LLC. This partnership involved CSI's investment in CarePICS' data-driven solution and digital Software as a Service (SaaS) product, aimed at elevating patient outcomes. CarePICS, based in the United States, operates as a telehealth company offering a virtual care platform specifically designed to enhance outcomes for individuals affected by critical limb ischemia (CLI). The strategic investment by CSI in CarePICS demonstrates a commitment to leveraging advanced technology and data-driven solutions to improve patient care and treatment effectiveness within the critical limb ischemia domain.

Major companies operating in the critical limb ischemia market report are Medtronic Plc, Boston Scientific Corporation, ThermoGenesis Holdings Inc., Abbott Laboratories, Pluri Biotech Ltd., Rexgenero Ltd., LimFlow SA, Micro Medical Solutions, Cardiovascular Systems Inc., Cynata Therapeutics Ltd, Shanghai MicroPort Medical (Group) Co Ltd., B. Braun SE, Teva Pharmaceutical Industries Ltd., Aldagen Inc., Cook Medical, Philips, BD, Penumbra Inc., Cardinal Health Inc., Teleflex Incorporated, AngioDynamics Inc., Endologix Inc., Terumo Corporation, Teleflex, MicroPort Scientific, Silk Road Medical, LeMaitre Vascular Inc., Merit Medical Systems Inc., Shockwave Medical, Avinger, Biomerics LLC, Intact Vascular Inc., Soundbite Medical Solutions, Bluegrass Vascular Technologies, PQ Bypass, Vasorum Ltd, Rex Medical, Otsuka Medical Devices, Aortica Corporation.

North America was the largest region in the critical limb ischemia treatment market in 2023. The regions covered in the critical limb ischemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the critical limb ischemia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The critical limb ischemia treatment market includes revenues earned by entities by providing angioplasty, stents and laser atherectomy treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Critical Limb Ischemia Market Characteristics

3. Critical Limb Ischemia Market Trends And Strategies

4. Critical Limb Ischemia Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Critical Limb Ischemia Market Size and Growth

• 5.1. Global Critical Limb Ischemia Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Critical Limb Ischemia Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Critical Limb Ischemia Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Critical Limb Ischemia Market Segmentation

• 6.1. Global Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Devices
• Drugs
• Surgery
• 6.2. Global Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Antihypertensive Agents
• Antiplatelet Drugs
• Antithrombotic Agents
• Other Medications
• 6.3. Global Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital
• Clinic
• Other Applications

7. Critical Limb Ischemia Market Regional And Country Analysis

• 7.1. Global Critical Limb Ischemia Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Critical Limb Ischemia Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Critical Limb Ischemia Market

• 8.1. Asia-Pacific Critical Limb Ischemia Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Critical Limb Ischemia Market

• 9.1. China Critical Limb Ischemia Market Overview
• 9.2. China Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Critical Limb Ischemia Market

• 10.1. India Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Critical Limb Ischemia Market

• 11.1. Japan Critical Limb Ischemia Market Overview
• 11.2. Japan Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Critical Limb Ischemia Market

• 12.1. Australia Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Critical Limb Ischemia Market

• 13.1. Indonesia Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Critical Limb Ischemia Market

• 14.1. South Korea Critical Limb Ischemia Market Overview
• 14.2. South Korea Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Critical Limb Ischemia Market

• 15.1. Western Europe Critical Limb Ischemia Market Overview
• 15.2. Western Europe Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Critical Limb Ischemia Market

• 16.1. UK Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Critical Limb Ischemia Market

• 17.1. Germany Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Critical Limb Ischemia Market

• 18.1. France Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Critical Limb Ischemia Market

• 19.1. Italy Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Critical Limb Ischemia Market

• 20.1. Spain Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Critical Limb Ischemia Market

• 21.1. Eastern Europe Critical Limb Ischemia Market Overview
• 21.2. Eastern Europe Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Critical Limb Ischemia Market

• 22.1. Russia Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Critical Limb Ischemia Market

• 23.1. North America Critical Limb Ischemia Market Overview
• 23.2. North America Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Critical Limb Ischemia Market

• 24.1. USA Critical Limb Ischemia Market Overview
• 24.2. USA Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Critical Limb Ischemia Market

• 25.1. Canada Critical Limb Ischemia Market Overview
• 25.2. Canada Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Critical Limb Ischemia Market

• 26.1. South America Critical Limb Ischemia Market Overview
• 26.2. South America Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Critical Limb Ischemia Market

• 27.1. Brazil Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Critical Limb Ischemia Market

• 28.1. Middle East Critical Limb Ischemia Market Overview
• 28.2. Middle East Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Critical Limb Ischemia Market

• 29.1. Africa Critical Limb Ischemia Market Overview
• 29.2. Africa Critical Limb Ischemia Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Critical Limb Ischemia Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Critical Limb Ischemia Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Critical Limb Ischemia Market Competitive Landscape And Company Profiles

• 30.1. Critical Limb Ischemia Market Competitive Landscape
• 30.2. Critical Limb Ischemia Market Company Profiles
  • 30.2.1. Medtronic Plc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Boston Scientific Corporation
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. ThermoGenesis Holdings Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Abbott Laboratories
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Pluri Biotech Ltd.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Critical Limb Ischemia Market Competitive Benchmarking

32. Global Critical Limb Ischemia Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Critical Limb Ischemia Market

34. Critical Limb Ischemia Market Future Outlook and Potential Analysis

• 34.1 Critical Limb Ischemia Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Critical Limb Ischemia Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Critical Limb Ischemia Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer